The real deal here is lots of people trying to hold down the price. Interested in accumulating or covering. Whatever. the real deal is the PPS is GOING UP. The announcements of distribution deals CXM already has set up - the estimates of sales - all that stuff will cause the PPS to climb.
It can be manipulated without that, so hold on.
I usually say DYODD and beware of the risk because this is a biotech. The risk is behind us at this point and the Value is about to come home to roost.
Fellow enduring longs, enjoy the next few days...
I have to agree with you there. This stock could end up under dime if they don't star posting some positive money. Wall street hates stocks like this that PUMP deals and give little if any real numbers to work with..
Think in months instead of weeks and please be realistic in terms of targets.
Most of us have waited this long to see Excellagen getting approved. Surely we can wait another few months to see the PPS climb. How high is anybodies guess but it won't stay below $1 that's for sure with what we know now.
Cheers to all longs for being patient and keeping the faith.
Looking for next July to be back on Russell with price at least $4-$5 and if Generx start movIng with good news then $8-$10.
We should get follow up news soon about partnership/distribution agreements, etc.
Stay Tuned, it's only the beggining.
Oh I am Headnorth... methinks I'm taking off after lunch and celebrating. Waited a long time for this one.
I'm not sure I agree it will be 8$ by Christmas though; by my figures Cardium with take 20% +/- of the ulcerous wound care market in the 4th quarter 2011 here.
It won't be until April-May 2012 that cardium see's 8-10$ a share imo after publishing 4-Quarter 2011 results and 1st Quarter 2012 results - by which point Exellagen should be at minimum 40%+ of the diabetic ulcer treatment market.
By Christmas I crunch numbers and come up with 5-5.50 a share - pending no major run-ups, which with biotechs, always went to happen when drugs are approved by the FDA, Produced and Sold.
Beautiful, beautiful Monday today my fellow longs.
In 6 months Cardium will control 40 or more of a 150million dollar+ per year continual revenue stream.
75%+ in a year.
Cardium will be 12-15$ pps this time next year.
Proud to have stayed long and strong over 2 1/2 years with Cardium
I thought you had left. I guess you just got tired of the bashers.
I'm glad we held on. This is going to be great, long term.
The numbers I calculated were based on 100% market share, so I guess your timing is more reasonable.
The thing is, Regranex really isn't an alternative - besides the problems, it is said to not work nearly as well. So when this stuff hits the market, the market may be bigger than the current market for Regranex.
I really like the fact that CXM will now be able to fund the studies in Generx. That will make for a very wonderful expansion.
Just glad you hung on to enjoy this...